← Back to Search

Other

Topical Latanoprost/Minoxidil formulation for Alopecia Areata

Phase < 1
Recruiting
Led By Dan Cosgrove, M.D.
Research Sponsored by Aneira Pharma, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial is testing a new combination treatment to see if it can safely help people with thinning eyebrows.

Eligible Conditions
  • Alopecia Areata

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Target Area Hair Count
Secondary outcome measures
Change in Total Area Hair Darkness
Standardized Global Photographs
Other outcome measures
Subject Self Assessment

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Topical Latanoprost/Minoxidil formulationExperimental Treatment1 Intervention
8 participants: Topical Latanoprost/Minoxidil formulation applied to both eyebrows once a day for 90 days
Group II: Control GroupPlacebo Group1 Intervention
4 participants: Vehicle applied to both eyebrows once a day for 90 days

Find a Location

Who is running the clinical trial?

Aneira Pharma, Inc.Lead Sponsor
1 Previous Clinical Trials
14 Total Patients Enrolled
1 Trials studying Alopecia Areata
14 Patients Enrolled for Alopecia Areata
Dan Cosgrove, M.D.Principal InvestigatorWellMax
~6 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top